Quinz is a leading life sciences law firm. Our team has more than 15 years of experience in the life sciences industry, including pharma, biotech, MedTech, and Healthtech. We offer top-tier advisory and transactional services to multinationals, start-ups, scale-ups, clinical stage ventures, life sciences venture capital and private equity funds.
We are full-service. We assist in strategic transactions and operational contracts. We advise on regulatory requirements relevant to the development and commercialization of products and technologies. We help to ensure compliance in the use of patient data, interactions with patients and health care practitioners, and collaborations with competitors.
We are multidisciplinary. With expertise spanning diverse fields (including corporate, regulatory, competition, commercial, data privacy, and intellectual property law), we bring a 360-degree approach to every project. We are a team that thrives on the power of multiple perspectives. Together, we are not just a team, we are a strategic advantage for our clients.
We operate across the EU. Quinz has a network of associated firms and specialists that expand our geographic reach and strengthen our industry expertise.
We make every effort to provide prompt, pragmatic, and diligent legal support and are committed to building long-term relationships with our clients.
Recognized for its excellence, our Life sciences practice is ranked as Tier 1 by Legal 500. Life sciences (Domestic) is ranked as Band 2 by Chambers Europe. Olivier Van Obberghen and Pieter Wyckmans are ranked as Band 2 and Marion Lapage is ranked as Up and Coming by Chambers Europe. This acknowledgement reflects our unwavering commitment to achieving the best possible outcome for our clients.
